<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04010162</url>
  </required_header>
  <id_info>
    <org_study_id>UU-SUAM-MREC-2018-13/11</org_study_id>
    <nct_id>NCT04010162</nct_id>
  </id_info>
  <brief_title>Mesh Debate Awareness Among Non-urogynecologists. A Practical Survey Study.</brief_title>
  <acronym>Mesh_Survey</acronym>
  <official_title>Social Media Awareness Level of Non-urogynecologist Doctors About the Current Mesh Discussions in Urogynecology: A Practical Survey Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uludag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King's College Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Uludag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the awareness of mesh discussions in urogynecology among
      non-urogynecologists. A web-based questionnaire will be sent to four groups. Group-1 is
      King's College Hospital doctors. Group-2 is Uludag University Hospital doctors. Group-3 is
      doctors from the United States, and Group-4 is doctors from all over the world.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There has been a great deal of discussion about mesh complications in urogynecology. During
      the following decade, vaginal mesh operations for pelvic organ prolapse increased
      exponentially all over the world, particularly in the United States. Once the complications
      started to increase, the publication of mesh-related complications on social and broadcast
      media and the increase of medico-legal claims the United States led to an extensive FDA (Food
      and Drug Administration) restriction on vaginal mesh procedures in 2013. On January 5, 2016,
      the FDA reclassified surgical mesh for transvaginal repair of the pelvic organ prolapse into
      class III, which require premarket approval. Finally, on April 16, 2019, the FDA ordered all
      manufacturers of urogynecological mesh intended for transvaginal repair to stop selling and
      distributing their products immediately. However, awareness of the other doctors in branches
      of medicine outside of gynecology and urology is unknown.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">September 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Awareness of the current mesh discussion in urogynecology.</measure>
    <time_frame>1 minute</time_frame>
    <description>Web-based survey about current mesh discussion in Urogynecology with ten simple questions will be answered by the doctors in four groups (Question-8).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Social media awareness about the mesh discussions in urogynecology</measure>
    <time_frame>1 minute</time_frame>
    <description>Web-based survey about current mesh discussion in Urogynecology with ten simple questions will be answered by the doctors in four groups (Question-10).</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <condition>Urinary Incontinence</condition>
  <condition>Complication of Surgical Procedure</condition>
  <arm_group>
    <arm_group_label>Group-1: King's College Hospital</arm_group_label>
    <description>Doctors in King's College Hospital, London, The United Kingdom (Excluding Urology and Gynecology)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group-2: Uludag University Hospital</arm_group_label>
    <description>Doctors in Uludag University Hospital, Bursa, Turkey (Excluding Urology and Gynecology)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group-3: The United States</arm_group_label>
    <description>Doctors from The United States (Excluding Urology and Gynecology)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group-4: The World</arm_group_label>
    <description>Doctors from all over the world (Excluding Urology and Gynecology)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mesh debate awareness survey</intervention_name>
    <description>A web-based questionnaire with questions about recent discussions of mesh in urogynecology.
10 questions. Average survey completion time: 1 minute</description>
    <arm_group_label>Group-1: King's College Hospital</arm_group_label>
    <arm_group_label>Group-2: Uludag University Hospital</arm_group_label>
    <arm_group_label>Group-3: The United States</arm_group_label>
    <arm_group_label>Group-4: The World</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Doctors from four different groups (1-KCH, 2-UUH, 3-USA, 4-WORLD) are expected to complete
        the questionnaire.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Doctors from all branches of medicine

          -  Basic sciences: Immunology, Medical Biochemistry, Microbiology and Infectious
             Diseases, Forensic Medicine, Family Medicine, Public Health, Medical genetics, Medical
             pharmacology.

          -  Pediatrics: Pediatric allergy, Pediatric respiratory, Pediatric dentistry, Pediatric
             endocrinology, Pediatric gastroenterology and nutrition, Pediatric haematology,
             Pediatric nephrology, Pediatric neurology, Pediatric oncology, Pediatric
             ophthalmology, Pediatric surgery, Child and adolescent psychiatry, Pediatric
             orthopedics.

          -  Basic internal medicine specialties: Gastroenterology, Medical Oncology, Rheumatology,
             Hematology, Nephrology, Endocrinology

          -  Other internal medicine specialties: Neurology, Nuclear medicine, Radiology, Radiation
             Oncology, Psychiatry, Sport medicine, Respiratory medicine, Physical medicine and
             rehabilitation, Geriatrics, Dermatology, Cardiology

          -  Surgical Departments: Emergency and Accident Medicine, Heart and vascular surgery,
             Ophthalmatology, Orthopedics and Traumatology, Plastic and reconstructive surgery,
             Medical pathology, Anesthesiology and reanimation, Neurosurgery, General surgery,
             Chest surgery

        Exclusion Criteria:

          -  Obstetricians and Gynaecologists,

          -  Urogynecologists,

          -  Urologists,

          -  Perinatologists ,

          -  Gynecological Oncologists,

          -  Doctors from Reproductive Endocrinology and Infertility,

          -  Uro-oncologists

          -  Andrologists.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kemal Ozerkan, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Uludag University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adnan Orhan, M.D.</last_name>
    <phone>+905056337102</phone>
    <email>dr.adnan.orhan@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Angela Rantell, PhD</last_name>
    <phone>+44 (0)20 3299 3568</phone>
    <email>angela.rantell@nhs.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uludag University Hospital, Department of Obstetrics and Gynecology</name>
      <address>
        <city>Bursa</city>
        <state>Ozluce</state>
        <zip>16059</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adnan Orhan, M.D.</last_name>
      <phone>+90 505 6337102</phone>
      <email>dr.adnan.orhan@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Isil Kasapoglu, M.D</last_name>
      <phone>+905305455848</phone>
      <email>kasapogluisil@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Lensen EJ, Withagen MI, Kluivers KB, Milani AL, Vierhout ME. Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the anterior compartment. Int Urogynecol J. 2013 Oct;24(10):1593-602. doi: 10.1007/s00192-013-2074-2. Epub 2013 Mar 15. Review.</citation>
    <PMID>23494056</PMID>
  </reference>
  <reference>
    <citation>LANE FE. Repair of posthysterectomy vaginal-vault prolapse. Obstet Gynecol. 1962 Jul;20:72-7.</citation>
    <PMID>14462011</PMID>
  </reference>
  <reference>
    <citation>Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Brown J. Surgery for women with anterior compartment prolapse. Cochrane Database Syst Rev. 2016 Nov 30;11:CD004014. Review.</citation>
    <PMID>27901278</PMID>
  </reference>
  <reference>
    <citation>Nygaard IE, McCreery R, Brubaker L, Connolly A, Cundiff G, Weber AM, Zyczynski H; Pelvic Floor Disorders Network. Abdominal sacrocolpopexy: a comprehensive review. Obstet Gynecol. 2004 Oct;104(4):805-23. Review.</citation>
    <PMID>15458906</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 2, 2019</study_first_submitted>
  <study_first_submitted_qc>July 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2019</study_first_posted>
  <last_update_submitted>July 5, 2019</last_update_submitted>
  <last_update_submitted_qc>July 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Uludag University</investigator_affiliation>
    <investigator_full_name>Adnan Orhan</investigator_full_name>
    <investigator_title>Medical Doctor, Researcher, Obstetrician and Gynecologist</investigator_title>
  </responsible_party>
  <keyword>mesh complications</keyword>
  <keyword>social media awareness</keyword>
  <keyword>knowledge of doctors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

